Astrazeneca Plc Adr Stock Short Ratio

AZN Stock

USD 68.55 0.19 0.28%

AstraZeneca PLC ADR fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AstraZeneca PLC ADR Company Short Ratio Analysis

AstraZeneca PLC's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current AstraZeneca PLC Short Ratio

1.61 X

Most of AstraZeneca PLC's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AstraZeneca PLC ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

AstraZeneca Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for AstraZeneca PLC is extremely important. It helps to project a fair market value of AstraZeneca Stock properly, considering its historical fundamentals such as Short Ratio. Since AstraZeneca PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AstraZeneca PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AstraZeneca PLC's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Capital Stock	Common Stock	Intangible Assets	Long Term Debt	Good Will	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital
Total Assets		0.9	0.85	-0.38	0.3	-0.36	0.96	0.69	0.79	0.74	0.74	0.96	0.79	1.0	0.83	0.5	0.83	-0.66	0.69	-0.36	0.6	0.68	0.63	0.8	0.09
Total Stockholder Equity	0.9		0.65	-0.2	0.11	-0.22	0.74	0.76	0.75	0.69	0.69	0.82	0.57	0.91	0.65	0.47	0.8	-0.3	0.41	0.01	0.26	0.48	0.51	0.84	-0.04
Net Debt	0.85	0.65		-0.78	0.23	-0.53	0.89	0.34	0.73	0.65	0.65	0.9	0.81	0.86	0.87	0.61	0.86	-0.83	0.84	-0.46	0.82	0.83	0.7	0.81	0.15
Retained Earnings	-0.38	-0.2	-0.78		-0.03	0.6	-0.47	0.13	-0.47	-0.35	-0.35	-0.49	-0.49	-0.41	-0.62	-0.68	-0.69	0.63	-0.72	0.33	-0.68	-0.69	-0.65	-0.59	-0.12
Accounts Payable	0.3	0.11	0.23	-0.03		-0.06	0.4	0.44	-0.05	0.51	0.51	0.32	0.62	0.28	0.36	0.1	0.0	-0.39	0.42	-0.49	0.36	0.01	0.31	0.15	0.65
Short Term Investments	-0.36	-0.22	-0.53	0.6	-0.06		-0.42	0.1	-0.28	-0.22	-0.22	-0.47	-0.4	-0.36	-0.39	-0.44	-0.49	0.44	-0.49	0.36	-0.41	-0.43	-0.44	-0.43	-0.09
Total Liab	0.96	0.74	0.89	-0.47	0.4	-0.42		0.58	0.73	0.69	0.69	0.96	0.86	0.95	0.86	0.48	0.77	-0.82	0.82	-0.57	0.76	0.74	0.66	0.7	0.17
Total Current Assets	0.69	0.76	0.34	0.13	0.44	0.1	0.58		0.42	0.81	0.81	0.55	0.63	0.67	0.63	0.3	0.46	-0.12	0.39	-0.01	0.24	0.33	0.53	0.59	0.25
Short Term Debt	0.79	0.75	0.73	-0.47	-0.05	-0.28	0.73	0.42		0.53	0.53	0.76	0.46	0.82	0.66	0.5	0.8	-0.5	0.58	-0.1	0.48	0.68	0.56	0.7	-0.41
Capital Stock	0.74	0.69	0.65	-0.35	0.51	-0.22	0.69	0.81	0.53		1.0	0.72	0.87	0.74	0.86	0.48	0.62	-0.47	0.72	-0.25	0.59	0.54	0.77	0.81	0.27
Common Stock	0.74	0.69	0.65	-0.35	0.51	-0.22	0.69	0.81	0.53	1.0		0.72	0.87	0.74	0.86	0.48	0.62	-0.47	0.72	-0.25	0.59	0.54	0.77	0.81	0.27
Intangible Assets	0.96	0.82	0.9	-0.49	0.32	-0.47	0.96	0.55	0.76	0.72	0.72		0.82	0.97	0.81	0.46	0.79	-0.78	0.73	-0.47	0.68	0.66	0.59	0.8	0.11
Long Term Debt	0.79	0.57	0.81	-0.49	0.62	-0.4	0.86	0.63	0.46	0.87	0.87	0.82		0.78	0.9	0.45	0.61	-0.77	0.86	-0.56	0.83	0.67	0.74	0.71	0.45
Good Will	1.0	0.91	0.86	-0.41	0.28	-0.36	0.95	0.67	0.82	0.74	0.74	0.97	0.78		0.82	0.5	0.84	-0.66	0.69	-0.35	0.59	0.68	0.63	0.82	0.04
Property Plant Equipment	0.83	0.65	0.87	-0.62	0.36	-0.39	0.86	0.63	0.66	0.86	0.86	0.81	0.9	0.82		0.69	0.82	-0.69	0.93	-0.4	0.83	0.83	0.91	0.8	0.24
Current Deferred Revenue	0.5	0.47	0.61	-0.68	0.1	-0.44	0.48	0.3	0.5	0.48	0.48	0.46	0.45	0.5	0.69		0.83	-0.28	0.65	-0.02	0.43	0.52	0.86	0.66	0.12
Net Receivables	0.83	0.8	0.86	-0.69	0.0	-0.49	0.77	0.46	0.8	0.62	0.62	0.79	0.61	0.84	0.82	0.83		-0.49	0.71	-0.13	0.54	0.77	0.81	0.87	-0.02
Net Tangible Assets	-0.66	-0.3	-0.83	0.63	-0.39	0.44	-0.82	-0.12	-0.5	-0.47	-0.47	-0.78	-0.77	-0.66	-0.69	-0.28	-0.49		-0.81	0.8	-0.89	-0.64	-0.47	-0.44	-0.2
Long Term Investments	0.69	0.41	0.84	-0.72	0.42	-0.49	0.82	0.39	0.58	0.72	0.72	0.73	0.86	0.69	0.93	0.65	0.71	-0.81		-0.61	0.91	0.8	0.88	0.62	0.23
Short Long Term Debt	-0.36	0.01	-0.46	0.33	-0.49	0.36	-0.57	-0.01	-0.1	-0.25	-0.25	-0.47	-0.56	-0.35	-0.4	-0.02	-0.13	0.8	-0.61		-0.61	-0.32	-0.25	-0.07	-0.33
Deferred Long Term Liab	0.6	0.26	0.82	-0.68	0.36	-0.41	0.76	0.24	0.48	0.59	0.59	0.68	0.83	0.59	0.83	0.43	0.54	-0.89	0.91	-0.61		0.79	0.68	0.48	0.21
Long Term Debt Total	0.68	0.48	0.83	-0.69	0.01	-0.43	0.74	0.33	0.68	0.54	0.54	0.66	0.67	0.68	0.83	0.52	0.77	-0.64	0.8	-0.32	0.79		0.71	0.61	0.02
Capital Surpluse	0.63	0.51	0.7	-0.65	0.31	-0.44	0.66	0.53	0.56	0.77	0.77	0.59	0.74	0.63	0.91	0.86	0.81	-0.47	0.88	-0.25	0.68	0.71		0.72	0.19
Net Invested Capital	0.8	0.84	0.81	-0.59	0.15	-0.43	0.7	0.59	0.7	0.81	0.81	0.8	0.71	0.82	0.8	0.66	0.87	-0.44	0.62	-0.07	0.48	0.61	0.72		0.13
Net Working Capital	0.09	-0.04	0.15	-0.12	0.65	-0.09	0.17	0.25	-0.41	0.27	0.27	0.11	0.45	0.04	0.24	0.12	-0.02	-0.2	0.23	-0.33	0.21	0.02	0.19	0.13

Click cells to compare fundamentals

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

Competition

Predict AstraZeneca PLC

AstraZeneca Price To Sales Ratio

Price To Sales Ratio

2.62

At this time, AstraZeneca PLC's Price To Sales Ratio is very stable compared to the past year.

Based on the latest financial disclosure, AstraZeneca PLC ADR has a Short Ratio of 1.61 times. This is 58.72% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 59.75% higher than that of the company.

AstraZeneca Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AstraZeneca PLC's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics of similar companies.

AstraZeneca PLC is currently under evaluation in short ratio category among related companies.

AstraZeneca PLC Institutional Holders

Institutional Holdings refers to the ownership stake in AstraZeneca PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AstraZeneca PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AstraZeneca PLC's value.

		Shares
Atlantic Trust Group, Llc	2023-12-31	10.4 M
Franklin Resources Inc	2023-12-31	9.8 M
Fisher Asset Management, Llc	2023-12-31	9.4 M
Capital World Investors	2023-12-31	9.3 M
Putnam Investments Llc	2023-12-31	7.7 M
Blackrock Inc	2023-12-31	6.5 M
Ameriprise Financial Inc	2023-12-31	4.4 M
Dimensional Fund Advisors, Inc.	2023-12-31	4 M
Farallon Capital Management, L.l.c.	2023-12-31	3.8 M
T. Rowe Price Associates, Inc.	2023-12-31	52.3 M
Wellington Management Company Llp	2023-12-31	49.4 M

AstraZeneca Fundamentals

	Return On Equity	0.16
	Return On Asset	0.066
	Profit Margin	0.13 %
	Operating Margin	0.17 %
	Current Valuation	129.78 B
	Shares Outstanding	3.1 B
	Shares Owned By Institutions	16.80 %
	Number Of Shares Shorted	7.66 M
	Price To Earning	103.39 X
	Price To Book	5.46 X
	Price To Sales	4.67 X
	Revenue	45.81 B
	Gross Profit	35.73 B
	EBITDA	13.91 B
	Net Income	6.9 B
	Cash And Equivalents	4.52 B
	Cash Per Share	1.46 X
	Total Debt	28.62 B
	Debt To Equity	0.89 %
	Current Ratio	0.81 X
	Book Value Per Share	25.25 X
	Cash Flow From Operations	10.35 B
	Short Ratio	1.61 X
	Earnings Per Share	1.91 X
	Price To Earnings To Growth	0.89 X
	Target Price	81.81
	Number Of Employees	89.9 K
	Beta	0.19
	Market Capitalization	211.95 B
	Total Asset	101.12 B
	Retained Earnings	1.5 B
	Working Capital	(5.49 B)
	Current Asset	16.01 B
	Current Liabilities	14.87 B
	Annual Yield	0.02 %
	Five Year Return	2.99 %
	Net Asset	101.12 B
	Last Dividend Paid	2.9

About AstraZeneca PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.

Moving together with AstraZeneca Stock

0.75

YS Biopharma Report 22nd of April 2024

Pair Corr

Moving against AstraZeneca Stock

0.82	VCNX	Vaccinex	Pair Corr
0.67	DMTK	DermTech Financial Report 2nd of May 2024	Pair Corr
0.66	VCYT	Veracyte Financial Report 2nd of May 2024	Pair Corr
0.66	DRTS	Alpha Tau Medical Financial Report 28th of May 2024	Pair Corr
0.65	KA	Kineta Inc Financial Report 9th of May 2024	Pair Corr

The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.

The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:

How To Invest In AstraZeneca

Details

Is AstraZeneca Stock a good investment?

Details

What is AstraZeneca PLC's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out AstraZeneca PLC Piotroski F Score and AstraZeneca PLC Altman Z Score analysis.

Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account

Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.059

Dividend Share

2.9

Earnings Share

1.91

Revenue Per Share

2.4547

Quarterly Revenue Growth

0.073

The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Astrazeneca Plc Adr Stock Short Ratio

AstraZeneca PLC ADR Company Short Ratio Analysis

Short Ratio

Short Interest

Average Trading Volume

Current AstraZeneca PLC Short Ratio

AstraZeneca Short Ratio Driver Correlations

AstraZeneca Price To Sales Ratio

Price To Sales Ratio

2.62

AstraZeneca Short Ratio Peer Comparison

AstraZeneca PLC Institutional Holders

AstraZeneca Fundamentals

About AstraZeneca PLC Fundamental Analysis

Pair Trading with AstraZeneca PLC

Moving together with AstraZeneca Stock

Moving against AstraZeneca Stock

Complementary Tools for AstraZeneca Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY